Churchill Management Corp Bristol Myers Squibb CO Transaction History

Churchill Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $12,942 - $15,326	-189 Reduced 0.32%	58,153 $4.18 Million
Q4 2022 Jan 10, 2023	SELL	$68.48 - $81.09 $103,130 - $122,121	-1,506 Reduced 2.52%	58,342 $4.2 Million
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $76 - $45,335	590 Added 1.0%	59,848 $4.26 Million
Q2 2022 Jul 08, 2022	BUY	$72.62 - $79.98 $4.3 Million - $4.74 Million	59,258 New	59,258 $4.56 Million
Q4 2020 Jan 13, 2021	SELL	$57.74 - $65.43 $6.42 Million - $7.28 Million	-111,238 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$57.43 - $63.64 $312,821 - $346,647	5,447 Added 5.15%	111,238 $6.71 Million
Q2 2020 Jul 17, 2020	BUY	$54.82 - $64.09 $558,067 - $652,436	10,180 Added 10.65%	105,791 $6.22 Million
Q1 2020 Apr 09, 2020	BUY	$46.4 - $67.43 $62,547 - $90,895	1,348 Added 1.43%	95,611 $5.33 Million
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $4.64 Million - $6.05 Million	94,263 New	94,263 $6.05 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

Stay updated on Churchill Management Corp with notifications on news.